{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T00:03:14Z","timestamp":1783728194693,"version":"3.55.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001839","name":"University Grants Committee","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001839","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007179","name":"Advanced Centre for Treatment, Research and Education in Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007179","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","award":["2012-13\/25050"],"award-info":[{"award-number":["2012-13\/25050"]}],"id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.ijbiomac.2017.10.172","type":"journal-article","created":{"date-parts":[[2017,10,27]],"date-time":"2017-10-27T16:25:30Z","timestamp":1509121530000},"page":"729-743","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Process optimization and in vivo performance of docetaxel loaded PHBV-TPGS therapeutic vesicles: A synergistic approach"],"prefix":"10.1016","volume":"108","author":[{"given":"Harsh","family":"Vardhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooja","family":"Mittal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep Kumar Reddy","family":"Adena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansi","family":"Upadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarita Kumari","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brahmeshwar","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ijbiomac.2017.10.172_bib0005","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1021\/acsami.5b09585","article-title":"Smart cancer cell targeting imaging and drug delivery system by systematically engineering periodic mesoporous organosilica nanoparticles","volume":"8","author":"Lu","year":"2016","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.ijbiomac.2017.10.172_bib0010","first-page":"2174","article-title":"Recent advances in pH-sensitive polymeric nanoparticles for smart drug delivery in cancer therapy","volume":"17","author":"Lim","year":"2016","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.ijbiomac.2017.10.172_bib0015","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jconrel.2016.10.023","article-title":"Hybrid protein-inorganic nanoparticles: from tumor-targeted drug delivery to cancer imaging","volume":"243","author":"Elzoghby","year":"2016","journal-title":"J. Controlled Release"},{"issue":"5","key":"10.1016\/j.ijbiomac.2017.10.172_bib0020","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1039\/C5CS00798D","article-title":"Smart micro\/nanoparticles in stimulus-responsive drug\/gene delivery systems","volume":"45","author":"Karimi","year":"2016","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ijbiomac.2017.10.172_bib0025","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/B978-0-323-47347-7.00018-5","article-title":"Polymeric nanoparticles as siRNA drug delivery system for cancer therapy: the long road to therapeutic efficiency","author":"Fr\u00e8re","year":"2016","journal-title":"Nanoarchitectonics Smart Deliv. Drug Target."},{"key":"10.1016\/j.ijbiomac.2017.10.172_bib0030","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.1002\/adfm.201504185","article-title":"Magnetic nanoparticle facilitated drug delivery for cancer therapy with targeted and image-guided approaches","volume":"26","author":"Huang","year":"2016","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.ijbiomac.2017.10.172_bib0035","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jconrel.2016.07.051","article-title":"Role of nanoparticle size, shape and surface chemistry in oral drug delivery","volume":"238","author":"Banerjee","year":"2016","journal-title":"J. Controlled Release"},{"issue":"4","key":"10.1016\/j.ijbiomac.2017.10.172_bib0040","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1002\/chem.201503999","article-title":"Controlled multi-functionalization facilitates targeted delivery of nanoparticles to cancer cells","volume":"22","author":"Hudlikar","year":"2016","journal-title":"Chem. Eur. J."},{"issue":"2","key":"10.1016\/j.ijbiomac.2017.10.172_bib0045","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3109\/21691401.2014.971462","article-title":"Preparation, characterization, and optimization of altretamine-loaded solid lipid nanoparticles using Box-Behnken design and response surface methodology","volume":"44","author":"Gidwani","year":"2016","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2017.10.172_bib0050","first-page":"1912","article-title":"Development, optimization and evaluation of surfactant-based pulmonary nanolipid carrier system of paclitaxel for the management of drug resistance lung cancer using Box-Behnken design","volume":"23","author":"Kaur","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ijbiomac.2017.10.172_bib0055","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ejps.2016.12.007","article-title":"Long-circulating polyhydroxybutyrate-co-hydroxyvalerate nanoparticles for tumor targeted docetaxel delivery: formulation, optimization and in vitro characterization","volume":"99","author":"Vardhan","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2017.10.172_bib0060","author":"Smith","year":"2016","journal-title":"Clin. Breast Cancer"},{"key":"10.1016\/j.ijbiomac.2017.10.172_bib0065","unstructured":"S.E. Zale, G. Troiano, M.M. Ali, J. Hrkach, J. Wright, Long circulating nanoparticles for sustained release of therapeutic agents, Google Patents, 2016."},{"key":"10.1016\/j.ijbiomac.2017.10.172_bib0070","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.addr.2016.05.020","article-title":"PLA micro-and nano-particles","volume":"107","author":"Lee","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijbiomac.2017.10.172_bib0075","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.biortech.2015.11.046","article-title":"Production and characterization of poly (3-hydroxy butyrate-co-3 hydroxyvalerate)(PHBV) by a novel halotolerant mangrove isolate","volume":"201","author":"Moorkoth","year":"2016","journal-title":"Bioresour. Technol."},{"issue":"29","key":"10.1016\/j.ijbiomac.2017.10.172_bib0080","doi-asserted-by":"crossref","first-page":"5035","DOI":"10.1039\/C6TB00113K","article-title":"Multilayered drug delivery coatings composed of daidzein-loaded PHBV microspheres embedded in a biodegradable polymer matrix by electrophoretic deposition","volume":"4","author":"Chen","year":"2016","journal-title":"J. Mater. Chem. B"},{"issue":"1","key":"10.1016\/j.ijbiomac.2017.10.172_bib0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.colsurfb.2009.09.001","article-title":"Biodegradable polymeric nanoparticles based drug delivery systems","volume":"75","author":"Kumari","year":"2010","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.ijbiomac.2017.10.172_bib0090","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ejps.2016.09.035","article-title":"Risk management and statistical multivariate analysis approach for design and optimization of satranidazole nanoparticles","volume":"96","author":"Dhat","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.ijbiomac.2017.10.172_bib0095","first-page":"683","article-title":"Development and optimization of solid lipid nanoparticle formulation for ophthalmic delivery of chloramphenicol using a Box-Behnken design","volume":"6","author":"Hao","year":"2011","journal-title":"Int. J. Nanomed."},{"issue":"1","key":"10.1016\/j.ijbiomac.2017.10.172_bib0100","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ijpharm.2006.09.060","article-title":"Quality by design: understanding the formulation variables of a cyclosporine A self-nanoemulsified drug delivery systems by Box\u2013Behnken design and desirability function","volume":"332","author":"Zidan","year":"2007","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.ijbiomac.2017.10.172_bib0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpb.2007.08.001","article-title":"Nanoparticles for drug delivery: the need for precision in reporting particle size parameters","volume":"69","author":"Gaumet","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"13","key":"10.1016\/j.ijbiomac.2017.10.172_bib0110","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1016\/j.biomaterials.2010.01.065","article-title":"Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles","volume":"31","author":"He","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijbiomac.2017.10.172_bib0115","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.chroma.2011.12.041","article-title":"Quality by design: multidimensional exploration of the design space in high performance liquid chromatography method development for better robustness before validation","volume":"1232","author":"Monks","year":"2012","journal-title":"J. Chromatogr. A"},{"issue":"5","key":"10.1016\/j.ijbiomac.2017.10.172_bib0120","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.tibtech.2016.01.003","article-title":"Quality by design (QbD)-based process development for purification of a biotherapeutic","volume":"34","author":"Rathore","year":"2016","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.ijbiomac.2017.10.172_bib0125","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jconrel.2016.04.019","article-title":"Inhibition of bone loss with surface-modulated, drug-loaded nanoparticles in an intraosseous model of prostate cancer","volume":"232","author":"Adjei","year":"2016","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.ijbiomac.2017.10.172_bib0130","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jconrel.2016.03.036","article-title":"Pharmacokinetic and pharmacodynamic study of a phospholipid-based phase separation gel for once a month administration of octreotide","volume":"230","author":"Wang","year":"2016","journal-title":"J. Controlled Release"},{"issue":"10","key":"10.1016\/j.ijbiomac.2017.10.172_bib0135","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1007\/s40262-016-0388-1","article-title":"A new level a type IVIVC for the rational design of clinical trials toward regulatory approval of generic polymeric long-acting injectables","volume":"55","author":"Somayaji","year":"2016","journal-title":"Clin. Pharmacokinet."},{"issue":"1","key":"10.1016\/j.ijbiomac.2017.10.172_bib0140","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ijpharm.2015.12.011","article-title":"A bimodal molecular imaging probe based on chitosan encapsulated magneto-fluorescent nanocomposite offers biocompatibility, visualization of specific cancer cells in vitro and lung tissues in vivo","volume":"498","author":"Walia","year":"2016","journal-title":"Int. J. Pharm."},{"issue":"6","key":"10.1016\/j.ijbiomac.2017.10.172_bib0145","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.addr.2009.03.009","article-title":"Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy","volume":"61","author":"Aggarwal","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"14","key":"10.1016\/j.ijbiomac.2017.10.172_bib0150","doi-asserted-by":"crossref","first-page":"6045","DOI":"10.1039\/C5NR00733J","article-title":"Interactions of PLGA nanoparticles with blood components: protein adsorption, coagulation, activation of the complement system and hemolysis studies","volume":"7","author":"Fornaguera","year":"2015","journal-title":"Nanoscale"},{"issue":"7","key":"10.1016\/j.ijbiomac.2017.10.172_bib0155","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1108\/02656710410549082","article-title":"Integration of FMEA and the Kano model: an exploratory examination","volume":"21","author":"Shahin","year":"2004","journal-title":"Int. J. Qual. Reliability Manage."},{"key":"10.1016\/j.ijbiomac.2017.10.172_bib0160","first-page":"408","article-title":"Quality risk management Q9","volume":"4","author":"Guideline","year":"2005","journal-title":"Curr. Step"},{"key":"10.1016\/j.ijbiomac.2017.10.172_bib0165","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.ijbiomac.2017.05.125","article-title":"Development of long-circulating docetaxel loaded poly (3-hydroxybutyrate-co-3-hydroxyvalerate) nanoparticles: optimization, pharmacokinetic, cytotoxicity and in vivo assessments","volume":"103","author":"Vardhan","year":"2017","journal-title":"Int. J. Biol. Macromol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2017.10.172_bib0170","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1208\/s12249-007-9023-7","article-title":"Design and evaluation of microemulsions for improved parenteral delivery of propofol","volume":"9","author":"Date","year":"2008","journal-title":"AAPS PharmSciTech"}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813017321219?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813017321219?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T07:14:25Z","timestamp":1758870865000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813017321219"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":34,"alternative-id":["S0141813017321219"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2017.10.172","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Process optimization and in vivo performance of docetaxel loaded PHBV-TPGS therapeutic vesicles: A synergistic approach","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2017.10.172","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}